Compare BAFN & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAFN | IRIX |
|---|---|---|
| Founded | 1999 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 25.8M |
| IPO Year | 2021 | 1996 |
| Metric | BAFN | IRIX |
|---|---|---|
| Price | $6.53 | $1.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.7K | ★ 58.1K |
| Earning Date | 04-30-2026 | 04-01-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | ★ 133.93 | 8.47 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $41,593,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | N/A | $8.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.72 | $0.78 |
| 52 Week High | $19.15 | $1.65 |
| Indicator | BAFN | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 49.59 |
| Support Level | $6.31 | $1.33 |
| Resistance Level | $8.26 | $1.51 |
| Average True Range (ATR) | 0.45 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.53 | 41.67 |
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.